The table below shows AMICUS THERAPEUTICS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Q1 2024
Revenue
$169.06M
$154.69M
$125.25M
$141.52M
$126.67M
$110.40M
Cost of revenue
$19.47M
$15.22M
$11.70M
$13.28M
$11.26M
$13.57M
Gross profit
$149.59M
$139.47M
$113.55M
$128.24M
$115.41M
$96.84M
R&D
-
-
-
-
-
-
FOLD annual revenue (10-K history)
AMICUS THERAPEUTICS, INC. reported annual revenue of $634.21M for fiscal year 2025. That is up 20.0% from $528.29M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $4.96M (FY 2016) to $634.21M. Figures come from the company's audited annual reports as filed with the SEC.
